Supernus Pharmaceuticals (SUPN) Beats Q4 Earnings and Revenue Estimates Supernus (SUPN) delivered earnings and revenue surprises of 44.23% and 12.18%, respectively, for the quarter ended December 2024. Do the…
Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference ROCKVILLE, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…
Supernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue Estimates Supernus (SUPN) delivered earnings and revenue surprises of 171.79% and 13.30%, respectively, for the quarter ended September 2024. Do the…
Busy Philipps Encourages Women to Take Charge of Their ADHD This Fall in Ongoing Collaboration with Supernus Pharmaceuticals and Qelbree ROCKVILLE, Md., Sept. 24, 2024 (GLOBE NEWSWIRE) -- In a continued collaboration with Supernus Pharmaceuticals, actress, author, podcaster,…
Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…
Supernus Pharmaceuticals (SUPN) Misses Q2 Earnings Estimates Supernus (SUPN) delivered earnings and revenue surprises of -2.70% and 13.12%, respectively, for the quarter ended June 2024. Do the…
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of…
Supernus Announces First Quarter 2024 Financial Results ROCKVILLE, Md., May 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on…
Supernus Pharmaceuticals exec sells over $500k in stock By Investing.com Supernus Pharmaceuticals exec sells over $500k in stock…
Supernus Pharmaceuticals exec sells $436k in stock By Investing.com Supernus Pharmaceuticals exec sells $436k in stock…
Supernus Pharmaceuticals executive sells over $2.1m in stock By Investing.com Supernus Pharmaceuticals executive sells over $2.1m in stock…
Supernus Pharmaceuticals executive trades company stock By Investing.com Supernus Pharmaceuticals executive trades company stock…